Skip to content

Methadone Versus Morphine for Orthopedic Surgery Patients

Effectiveness of Pre-Operative Methadone Versus Morphine for Post-Operative Analgesia in Orthopedic Surgery Patients

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00892606
Enrollment
75
Registered
2009-05-04
Start date
2009-01-31
Completion date
2013-12-31
Last updated
2017-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture, Pain, Postoperative

Keywords

Surgery, Orthopedic, Pain, Postoperative

Brief summary

The investigators propose to compare analgesia by methadone and ketamine with a combination of morphine and ketamine in orthopedic surgery patients with moderate to severe pain. The investigators hypothesize that when given with ketamine before surgical incision, methadone is more effective than morphine in reducing postoperative morphine consumption and reducing pain during movement.

Detailed description

Patients will receive 1-4 mg midazolam before being transferred to the operating room. All patients will receive standard ASA monitoring. In the operating room, the anesthesiologist will open a randomization envelope to determine patient group assignment (see below). Patients will be anesthetized with 0.2 mg/kg ketamine, 2 µg/kg fentanyl and propofol or etomidate IV. Muscle relaxant of the anesthesiologist's choice will be given and the patient will be intubated. After intubation, the computer-generated randomization codes stored in opaque envelopes will be opened. The patients will be randomized to one of two groups: 1. Methadone group: Patients will receive 0.2 mg/kg of methadone IV immediately after intubation 2. Control group: Patients will receive 0.2 mg/kg of morphine IV immediately after intubation The unblinded investigator will draw the drug and dilute to a total volume of 10 cc. This syringe will be handed to the anesthesia provider, who will administer the medication after induction. They will be maintained with oxygen, air and an inhalational agent of anesthesiologist's choice, targeted at BIS between 40 and 60. Additional analgesia will be provided with fentanyl in 50 µg increments as required throughout surgery. At the end of surgery the neuromuscular block will be reversed and patients will breathe spontaneously. Fentanyl will be titrated to maintain a respiratory rate of 12-15 breaths per minute to obtain an O2 saturation \> 95% and the other extubation criteria are met before tracheal extubation . The intraoperative use of narcotics, sedatives and anesthetic drugs will be noted. The type of surgery, the duration of surgery and use of additional analgesics and antiemetics will be noted. An investigator blinded to randomization will track the patients in the PACU. If rescue medication is necessary, morphine IV will be given in 2-4 mg increments up to a total of 20 mg. If the patients continue to report pain (VAS \> 4), IV hydromorphone will be given in 0.5 mg dose every 10-15 minutes until the patient has adequate analgesia (VAS \< 4), as decided by the PACU nurse. Patients will receive morphine patient-controlled analgesia (PCA) for pain relief as the primary analgesic. Percocet (Acetaminophen/Oxycodone 325 mg/5 mg) or Lortab (Acetaminophen/Hydrocodone 325/5 mg) will be prescribed as needed to maintain VRS \< 4. In the PACU, vital signs including respiratory rate, heart rate, non-invasive blood pressure, sedation score and oxygen saturation will be recorded every 15 minutes. VAS scores for pain will be obtained from the patient every 15 minutes until the patient is discharged to the floor. VAS (visual analog scale) is a 100-mm scale where 0 = no pain and 100 = worst pain imaginable. The investigator will record sedation scores every 15 minutes using the following scale until patient is discharged to the floor: 0-Patient is fully alert 1. Patient has intermittent sedation 2. Patient sedated but responsive to verbal stimuli 3. Patient unresponsive to verbal stimuli Patients will be seen at 8 am and 4 pm on the following day and will be contacted at home or in the hospital on POD 2 and 3 for information regarding pain scores and analgesic requirement. The initial dose of rescue analgesic and time it is given will be recorded. VAS at rest and on movement will be recorded, when the patients are seen or VRS will be recorded via phone contact. Morphine or other analgesics required during the first 24 and 48 hours after surgery, and times to first ambulation, first fluid, solid and flatus will be recorded, as will incidence and severity of postoperative nausea and vomiting be recorded. Our primary outcome will be opioid consumption during the 48 hours after surgery. All analgesics consumed will be converted to morphine equivalent. The secondary outcomes will be 1. Overall rescue analgesic, converted into equipotent doses compared between the two groups 2. Side effects with special attention paid to respiratory rate and possible respiratory depression, and PONV 3. Visual pain score at 48 h post-op.

Interventions

DRUGMethadone

Patients will receive 0.2 mg/kg of methadone IV immediately after intubation

DRUGMorphine

Patients will receive 0.2 mg/kg of morphine IV immediately after intubation

Sponsors

University of Louisville
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* ASA I-III * Ages 18-65 years * Presenting for lower extremity orthopedic surgery involving fracture of long bones at University of Louisville Hospital * Surgery expected to last more than one hour * Patient expected to have moderate to severe post-operative pain * Patient refused regional anesthesia or has a contraindication to regional anesthesia

Exclusion criteria

* Any known contraindications to methadone including hypothyroidism, Addison's disease, prostatic hypertrophy, or urethral stricture. * Difficulty or inability to understand the study or protocol * Known renal or hepatic dysfunction * BMI\> 35 * Known respiratory or cardiovascular problems, such as obstructive sleep apnea or oxygen saturation of less than 92% on room air * Taking any of the known drugs that induce or inhibit the cytochrome p450 enzyme systems. Common examples of these drugs are antifungal, antiretroviral, barbiturates, dexamethasone, and macrolide antibiotics. * Pregnancy * Taking preoperative opioids for more than 2 weeks before the surgery

Design outcomes

Primary

MeasureTime frameDescription
Opioid Consumption During the 48 Hours After Surgery48 hoursThe amount of opioid required for postoperative pain relief

Secondary

MeasureTime frameDescription
Number of Participants With Post Operative Nausea and Vomiting48 hoursrates subjects experienced PONV
Visual Pain Score48 hoursPatients rated their pain with the numerical VPS from 0 to 10, with 10 being the worst pain possible and 0 being no pain

Countries

United States

Participant flow

Participants by arm

ArmCount
Methadone
Patients received 2 µg/kg fentanyl, 0.2 mg/kg ketamine, and 0.2 mg/kg of methadone IV immediately after intubation
38
Methadone
Patients received 2 µg/kg fentanyl, 0.2 mg/kg ketamine, and 0.2 mg/kg of methadone IV immediately after intubation
38
Control
Patients received 2 µg/kg fentanyl, 0.2 mg/kg ketamine, and 0.2 mg/kg morphine
37
Control
Patients received 2 µg/kg fentanyl, 0.2 mg/kg ketamine, and 0.2 mg/kg morphine
37
Total150

Baseline characteristics

CharacteristicMethadoneControlTotal
Age, Continuous37 years
STANDARD_DEVIATION 13
35 years
STANDARD_DEVIATION 12
36 years
STANDARD_DEVIATION 12
Region of Enrollment
United States
38 participants37 participants75 participants
Sex: Female, Male
Female
7 Participants10 Participants17 Participants
Sex: Female, Male
Male
31 Participants27 Participants58 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 330 / 33
other
Total, other adverse events
0 / 330 / 33
serious
Total, serious adverse events
0 / 330 / 33

Outcome results

Primary

Opioid Consumption During the 48 Hours After Surgery

The amount of opioid required for postoperative pain relief

Time frame: 48 hours

ArmMeasureValue (MEAN)Dispersion
MethadoneOpioid Consumption During the 48 Hours After Surgery51 mgStandard Deviation 19
ControlOpioid Consumption During the 48 Hours After Surgery87 mgStandard Deviation 40
p-value: 0.0072ANOVA
Secondary

Number of Participants With Post Operative Nausea and Vomiting

rates subjects experienced PONV

Time frame: 48 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
MethadoneNumber of Participants With Post Operative Nausea and Vomiting9 Participants
ControlNumber of Participants With Post Operative Nausea and Vomiting3 Participants
p-value: 0.004ANOVA
Secondary

Visual Pain Score

Patients rated their pain with the numerical VPS from 0 to 10, with 10 being the worst pain possible and 0 being no pain

Time frame: 48 hours

ArmMeasureValue (MEAN)Dispersion
MethadoneVisual Pain Score5 units on a scaleStandard Deviation 3
ControlVisual Pain Score6 units on a scaleStandard Deviation 2
p-value: 0.0146ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026